Analysis of the Prognostic Factors of Extensive Disease Small-Cell Lung Cancer Patients in Tokushima University Hospital

Hirokazu Ogino(Tokushima University), Yasuhiko Nishioka(Tokushima University), Yuko Toyoda(Tokushima University), Makoto Tobiume(Tokushima University), Hisatsugu Goto(Tokushima University), Kokichi Arisawa(Tokushima University), Atsuro Saijo(Tokushima University), Toshifumi Tezuka(Tokushima University), Masaki Hanibuchi(Tokushima University), Satoshi Sakaguchi(Tokushima University Hospital), Soji Kakiuchi(Tokushima Prefectural Central Hospital), Kenji Otsuka(Tokushima University)
The Journal of Medical Investigation
January 1, 2016
10.2152/jmi.63.286
Cited by 11

Related Papers

Hepatocyte Growth Factor Induces Gefitinib Resistance of Lung Adenocarcinoma with Epidermal Growth Factor Receptor–Activating Mutations
|Cancer Research|2008|642
Expression profiles of non-small cell lung cancers on cDNA microarrays: Identification of genes for prediction of lymph-node metastasis and sensitivity to anti-cancer drugs
|Oncogene|2003|324
Prediction of sensitivity of advanced non-small cell lung cancers to gefitinib (Iressa, ZD1839)
|Human Molecular Genetics|2004|175
Genome-wide analysis of organ-preferential metastasis of human small cell lung cancer in mice.
|PubMed|2003|114
Genome-wide association study revealed novel loci which aggravate asymptomatic hyperuricaemia into gout
|Annals of the Rheumatic Diseases|2019|104